Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|1|1-2

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.1, 2018-01, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 97-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 3, 2011-09 ,pp. : 341-346

Bentham Science Publishers

Access to resources Recommend Favorite

Early intervention in amyotrophic lateral sclerosis: a case presentation

By Yorkston Kathryn  

Augmentative & Alternative Communication, Vol. 5, Iss. 1, 1989-01 ,pp. : 67-70

Informa Healthcare

Access to resources Recommend Favorite

Amyotrophic lateral sclerosis: Problems and prospects

By  

ANNALS OF NEUROLOGY, Vol. 74, Iss. 3, 2013-09 ,pp. : 309-316

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autonomic system and amyotrophic lateral sclerosis

By  

MUSCLE AND NERVE, Vol. 51, Iss. 5, 2015-05 ,pp. : 676-679

John Wiley & Sons Inc

Access to resources Recommend Favorite